merged_drug-prices-medicare.txt
<other>I need to analyze the article carefully to answer each question based only on the information provided.</other>

<question_number>1</question_number>
<answer>The $2,000 annual cap goes into effect next year, while the negotiated prices take effect in 2026</answer>

<question_number>2</question_number>
<answer>The number of drugs negotiated is set to increase in coming years, but Project 2025 argues the program should be repealed</answer>

<question_number>3</question_number>
<answer>Harris cast the tiebreaking vote for the legislation and has made efforts to "take on Big Pharma" among her first priorities as president</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>$730</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>Januvia</answer>

<other>Calculating: Januvia at $113/month would require approximately 17.7 monthly refills to reach $2,000</other>

<question_number>8</question_number>
<answer>92.5%</answer>

<other>The three most expensive are Imbruvica ($9,319), Stelara ($4,695), and Enbrel ($2,355), totaling $16,369 out of $17,699 total</other>

<question_number>9</question_number>
<answer>$19</answer>

<other>Jardiance ($197) and Farxiga ($178) both treat diabetes, heart failure and chronic kidney disease</other>

<question_number>10</question_number>
<answer>N/A</answer>